Overall, SKP1 amplifications (two or more additional copies) are rare (0–1.0%), while gains (one additional copy) occur in all 12 cancers analyzed and range from 3.2 to 30.7% in uterine and liver cancers, respectively. This evidence concerns the gene SKP1 and cancer.